# Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis

> **NCT00004990** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 20 (—)

## Conditions studied

- Glomerulonephritis
- Nephrotic Syndrome

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT00004990
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004990, "Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00004990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*